731
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Impact of the sustained control of cardiovascular risk factors on first episode heart failure: The relevant role of primary care

, , , , , , & show all
Pages 224-230 | Received 01 Aug 2014, Accepted 24 Apr 2015, Published online: 24 Jul 2015

REFERENCES

  • World Health Organization. The 10 leading causes of death in the world, 2000 and 2012. Fact sheet No. 310. Updated May 2014. Available at: http://who.int/mediacentre/factsheets/fs310/en/ (accessed 29 January 2015).
  • Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: Heart disease and stroke statistics—2013 update: A report from the American Heart Association. Circulation 2013;127:143–52.
  • Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5: 167–73.
  • Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, Psaty BM, Smith NL, Newman AB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: The health, aging, and body composition study. Arch Intern Med. 2009;169:708–15.
  • Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, Turner RM, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001;22:228–36.
  • Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137–46.
  • Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: An update. Diabetes Care 2004;27:1879–84.
  • Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Smith AL, Bauer DC, Newman AB, et al. Cigarette smoking exposure and heart failure risk in older adults: The health, aging, and body composition study. Am Heart J. 2012;164:236–42
  • Avery CL, Loehr LR, Baggett C, Chang PP, Kucharska-Newton AM, Matsushita K, et al. The population burden of heart failure attributable to modifiable risk factors: The ARIC (atherosclerosis risk in communities) study. J Am Coll Cardiol. 2012;60:1640–6.
  • Folsom AR, Yamagishi K, Hozawa A, Chambless LE. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail. 2009;2:11–7.
  • D’Agostino RB Jr. Propensity scores in cardiovascular research. Circulation 2007;115:2340–3.
  • Ho D, Imai K, King G, Stuart E. Matching as nonparametric pre-processing for reducing model dependence in parametric causal inference. Political Analysis 2007;15:199–236.
  • Austin PC. Optimal calliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150–61.
  • R Development Core Team. R: A language and environment for statistical computing. Vienna, R Foundation for Statistical Computing: 2008. Available at: http://www.R-project.org (accessed 4 May 2015).
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press 2014;23:3–16.
  • Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al. European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–701.
  • Tocci G, Sciarretta S, Volpe M. Development of heart failure in recent hypertension trials. J Hypertens. 2008;26:1477–86.
  • Black HR. The burden of cardiovascular disease: Following the link from hypertension to myocardial infarction and heart failure. Am J Hypertens. 2003;16(Suppl.2):4–6.
  • Butler J, Kalogeropoulos AP, Georgiopoulou VV, Bibbins-Domingo K, Najjar SS, Sutton-Tyrrell KC, et al. Systolic blood pressure and incident heart failure in the elderly. The cardiovascular health study and the health, ageing and body composition study. Heart 2011;97:1304–11.
  • Briasoulis A, Agarwal V, Tousoulis D, Stefanadis C. Effects of antihypertensive treatment in patients over 65 years of age: A meta-analysis of randomised controlled studies. Heart 2014;100:317–23.
  • JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115–27.
  • Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in elderly isolated systolic hypertension study. Hypertension 2010;56:196–202.
  • Loehr LR, Rosamond WD, Poole C, McNeill AM, Chang PP, Folsom AR, et al. Association of multiple anthropometrics of overweight and obesity with incident heart failure: The atherosclerosis risk in communities study. Circ Heart Fail. 2009;2:18–24.
  • Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk factors for heart failure: A population-based case-control study. Am J Med. 2009;122:1023–8.
  • Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: An update. Diabetes Care 2004;27:1879–8.
  • Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S. The relationship between glycaemic control and heart failure in 83 021 patients with type 2 diabetes. Diabetologia 2012;55:2946–5.
  • Macinko J, Starfield B, Shi L. The contribution of primary care systems to health outcomes within Organization for Economic Cooperation and Development (OECD) countries, 1970–1998. Health Serv Res. 2003;38:831–65.
  • Cancian M, Battaggia A, Celebrano M, Del Zotti F, Novelletto BF, Michieli R, et al. The care for chronic heart failure by general practitioners. Results from a clinical audit in Italy. Eur J Gen Pract. 2013;19:3–10.
  • Martin LD, Mathews S, Ziegelstein RC, Martire C, Howell EE, Hellmann DB, et al. Prevalence of asymptomatic left ventricular systolic dysfunction in at-risk medical inpatients. Am J Med. 2013;126:68–73.
  • Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, et al. Heart Failure Association of the European Society of Cardiology (HFA). EUR Observational Research Programme: Regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013; 15:808–17.
  • Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, et al. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Am J Med. 2013;126:393–400.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.